Table 4 Correlation between response and the ECOG status of the subjects at baseline

From: ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial

Interim Analysis

Physician-choice

ChemoID-Guided

p = 0.938

No Response

Response

No Response

Response

ECOG

0

5

0

2

2

1

33

2

18

18

2

1

0

0

0

Final Analysis

Physician-choice

ChemoID-Guided

p = 0.812

No Response

Response

No Response

Response

ECOG

0

5

0

1

2

1

33

2

14

17

2

1

0

0

0